LexaGene Holdings Inc. (LXG.V) Research

LexaGene Holdings Inc. is a biotechnology company focused on developing and commercializing sophisticated systems for pathogen detection. Their flagship product, MiQLab, is an automated platform engineered to transform pathogen identification within diverse markets, including veterinary and human clinical diagnostics, food and water safety, and various other life science applications. This advanced, automated system is deployed directly at the point of sample collection, offering unparalleled ease of use, high sensitivity, and the capacity to detect a wide range of pathogens. Founded in 2007, the company's headquarters are located in Beverly, Massachusetts.

Market snapshot

Symbol
LXG.V
Price
$0.11
Day change
0.00%
Market cap
$14.8M
52-week range
0.065-0.3
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Antibe Therapeutics Inc. (ATE.TO)
  • Cloud DX Inc. (CDX.V)
  • Chalice Brands Ltd. (CHAL.CN)
  • EXMceuticals Inc. (EXM.CN)
  • Fire & Flower Holdings Corp. (FAF.TO)
  • IMV Inc. (IMV.TO)
  • Numinus Wellness Inc. (NUMI.TO)
  • Reunion Neuroscience Inc. (REUN.TO)

Open LexaGene Holdings Inc. (LXG.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.